RecruitingNot ApplicableNCT03962920
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
Sponsor
Zealand University Hospital
Enrollment
28 participants
Start Date
May 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.
Eligibility
Min Age: 40 YearsMax Age: 70 Years
Inclusion Criteria1
- Biopsy verified diagnosis of urological cancer, localized disease
Exclusion Criteria5
- Hospitalization within three months of surgery
- Antibiotics within three months of surgery
- Infectious disease, including UTI's within three months of surgery
- History of cancers of the genitourinary tract
- Diabetes
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGTigecycline 50 MG
Local instillation of drug directly to the tumour tissue
OTHERPlacebo
Local instillation of sterile water directly to the tumour tissue
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03962920